ResMed | RMD - Le Bénéfice D'Exploitation

Prix De L'Action
252.87
Variation Quotidienne
-2.45 -0.96%
Mensuellement
-8.37%
Annuel
8.79%
Q1 Prévisions
245.13




Le Bénéfice D'Exploitation Changement Date
Ansell USD 146.5M 87.85M 2025-12
Artivion USD 4.39M 2.12M 2024-09
AtriCure USD 2.49M 2.28M 2025-12
Baxter International USD -214.2M 415.4M 2025-12
Cochlear AUD 261.1M 135.55M 2025-12
Cooper Companies USD 140.4M 35.3M 2025-09
CSL USD 2.64B 1.97B 2025-12
Dexcom USD 323M 80.5M 2025-12
Edwards Lifesciences USD 370.3M 54.8M 2025-12
Fisher Paykel Healthcare NZD 298.2M 2.8M 2025-12
Globus Medical USD 181.31M 298.83M 2025-12
Haemonetics USD 67.4M 8.9M 2025-12
Hologic USD 237M 16M 2025-12
Idexx Laboratories USD 315.6M 39.24M 2025-12
Inogen USD -7.79M 728K 2024-09
Insulet USD 146.3M 28.6M 2025-12
Integra LifeSciences USD 66M 54.24M 2025-12
Intuitive Surgical USD 865.3M 97.5M 2025-12
Masimo USD 83.9M 300K 2025-12
Medtronic USD 1.74B 40M 2025-12
Philips EUR 719M 390M 2025-12
Ramsay Health Care AUD 541.1M 3.9M 2025-12
ResMed USD 497.6M 35.25M 2025-12
Sigma Healthcare AUD 809K 13.76M 2024-12
Sonic Healthcare AUD 435.76M 193.66M 2024-12
Steris USD 278M 7.1M 2025-12
Teleflex USD 36.34M 445.24M 2025-12
Thermo Fisher Scientific USD 2.3B 226M 2025-12